In December 2008, after receiving a number of reports of kidney injury, the FDA required Salix to place a black box warning on the product, as to serious kidney damage occurring after use of OsmoPrep and also Visicol
Under the terms of the eighteen-month agreement, the P&GP gastrointestinal sales force will promote Visicol
to gastroenterologists and colorectal surgeons along with InKine's existing thirty sales representatives and three district managers.
is the first and only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy.
The report points to two specialty pharmaceutical product launches, Salix Pharmaceutical's Colazal for the treatment of acute ulcerative colitis and InKine Pharmaceutical's Visicol
(formerly Diacol) a colonic purging agent for use prior to colonoscopy, as potential value drivers in the gastroenterology market in 2001.
Tablets are virtually taste-free, can be taken with any clear liquid such as water, lemonade or ginger ale, and have been proven to be associated with significantly less nausea, vomiting and bloating than the leading, currently-available, prescribed class of liquid bowel preparations.